Ascelia Pharma AB: cashflow_investing

Value{"amount": 75991000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"}
Period2020-01-01 – 2020-12-31
Statuscurrent
EntityAscelia Pharma AB
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:5493002YR9VCJJPWYN08:2021-12-31
Retrieved: 2026-08-24T01:38:06.089351+02:00
Raw response sha256: 083ee476e82e5bf5489f72adcba22f97…
Cite as: FACTANKER, https://factanker.com/fact/89ff52ed-3da3-4e0f-9059-1cf7d2709aa5

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies